Accordingly, T cells from patients with fibrosing conditions, mainly IPF and HP, presented higher c-MET expression levels compared to CTD-ILD patients and healthy donors (Fig. 6D). The gene discussed is MET; the disease is idiopathic pulmonary fibrosis.